Skip to main content
Log in

Can β-Blockers be Used in Diabetic Patients?

  • Guest Editorial
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kotler, M.N.; Berman, L. and Rubenstein, A.H.: Hypoglycaemia precipitated by propranolol. Lancet 2: 1389–1390 (1966).

    Article  PubMed  CAS  Google Scholar 

  2. Wray, R. and Sutcliffe, S.B.J.: Propranolol-induced hypoglycaemia and myocardial infarction. British Medical Journal 2: 592 (1972).

    Article  PubMed  CAS  Google Scholar 

  3. Abramson, E.A.; Arky, R.A. and Woeber, K.A.: Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia. Lancet 2: 1386–1388 (1966).

    Article  PubMed  CAS  Google Scholar 

  4. Skinner, D.J. and Misbin, R.I.: Uses of propranolol. New England Journal of Medicine 293: 1205 (1975).

    Article  Google Scholar 

  5. Podolsky, S. and Pattavina, CG.: Hyperosmolar nonketotic diabetic coma: a complication of propranolol therapy. Metabolism 22: 685–693 (1973).

    Article  PubMed  CAS  Google Scholar 

  6. Reveno, W.S. and Rosenbaum, H.: Propranolol hypoglycaemia. Lancet 1: 920 (1968).

    Article  PubMed  CAS  Google Scholar 

  7. Fitzgerald, J.D.: Effects of propranolol on blood sugar, insulin and free fatty acids. Diabetologia 5: 339 (1968).

    Google Scholar 

  8. Davidson, M.McD.; Corrall, R.J.M.; Shaw, T.R.D. and French, E.B.: Observations in man of hypoglycaemia during selective and nonselective beta-blockade. Scottish Medical Journal 22: 69–72 (1976).

    Google Scholar 

  9. Deacon, S.P. and Barnett, D.: Comparison of atenolol and propranolol during muscular-induced hypoglycaemia. British Medical Journal 2: 272–273 (1976).

    Article  PubMed  CAS  Google Scholar 

  10. Newman, R.J. British Medical Journal 2: Comparison of propranolol, metoprolol and acebutolol on insulin-induced hypoglycaemia. Brit M. J. 2: 447–449 (1976).

    Article  PubMed  CAS  Google Scholar 

  11. Linton, S.P.; Scott, P.H. and Kendall, M.J.: Blood sugar and beta blockers. British Medical Journal 2: 877–878 (1976).

    Article  PubMed  CAS  Google Scholar 

  12. Deacon, S.P.; Karunanayaka, A. and Barnett, D.: Acebutolol, atenolol and propranolol and metabolic responses to acute hypoglycaemia in diabetics. British Medical Journal 2: 1255–1257 (1977).

    Article  PubMed  CAS  Google Scholar 

  13. Garber, A.J.; Cryer, P.E.; Santiago, J.V.; Haymond, M.W.; Pagliara, A.S. and Kipuis, D.M.: The role of the adrenergic mechanisms in the substrate and hormonal response to insulininduced hypoglycaemia in man. The Journal of Clinical Investigation 58: 7–15 (1976).

    Article  PubMed  CAS  Google Scholar 

  14. Ajlouni, K.; Sill, A.J. and Hagen, T.C.: Glucoregulation of prolactin secretion. Diabetes 25: Suppl. 1,121 (1976).

    Google Scholar 

  15. Campbell, L.V.; Kraegen, E.W. and Lazarus, L.: Defective blood glucose counter regulation in diabetics is a selective form of autonomic neuropathy. British Medical Journal 2: 1527–1529 (1977).

    Article  PubMed  CAS  Google Scholar 

  16. Lloyd-Mostyn, R.H. and Oram, S.: Modification by propranolol of cardiovascular effects of induced hypoglycaemia. Lancet 2: 1213–1215 (1975).

    Article  Google Scholar 

  17. Johnsson, G.: Influence of metoprolol and propranolol on hemodynamic effects induced by adrenaline and physical work. Acta Pharmacologica et Toxicologica 36: Suppl. 5, 59–68 (1975).

    PubMed  CAS  Google Scholar 

  18. Herwaarden, C.L.A.; Binkhorst R.A.; Fennis, J.F.M. and van’t Laar, A.: Effects of adrenaline during treatment with propranolol and metoprolol. Lancet 1: 1029 (1977).

    Google Scholar 

  19. McMurtry, R.L.: Propranolol, hypoglycaemia and hypertensive crisis. Annals of Internal Medicine 80: 669–670 (1974).

    PubMed  CAS  Google Scholar 

  20. Waal-Manning, H.J.: Metabolic effects of β-adrenoreceptor blockers. Drugs 11 (Suppl. 1): 121–126 (1976).

    Article  PubMed  Google Scholar 

  21. Ekberg, G. and Hansson, B.C.: Glucose tolerance and insulin release in hypertensive patients treated with the cardio-selective β-receptor blocking agent metoprolol. Acta Medica Scandinavica 202: 393–397 (1977).

    Article  PubMed  CAS  Google Scholar 

  22. Frohlich, E.D.; Tarazi, R.C. and Dustan, Harriet P.: Peripheral arterial insufficiency: a complication of beta-adrenergic blocking therapy. Journal of the American Medical Association 208: 2471–2472 (1969).

    Article  PubMed  CAS  Google Scholar 

  23. Marshall, A.J.; Roberts, C.J. and Barritt, D.W.: Raynaud’s phenomenon as a side effect of beta-blockers. British Medical Journal 1: 1498–1499 (1976).

    Article  PubMed  CAS  Google Scholar 

  24. Rand, J.J.; Law, M.; Story, D.F. and McCulloch, M.W.: Effects of β-adrenoceptor blocking drugs on adrenergic transmission. Drugs 11: (Suppl. I); 134–143 (1976).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waal-Manning, H.J. Can β-Blockers be Used in Diabetic Patients?. Drugs 17, 157–160 (1979). https://doi.org/10.2165/00003495-197917030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197917030-00002

Navigation